Isomorphic Labs Secures $600M to Advance AI Drug Design
Isomorphic Labs, a spinout from DeepMind, has raised $600 million in its first external funding round. The round was led by Thrive Capital, with participation from Google Ventures and Alphabet. This funding aims to accelerate the development of Isomorphic Labs' AI drug design engine and advance its drug candidates to clinical trials by the end of the year.
The company, headquartered in London with an office in Lausanne, Switzerland, is focused on reducing the time required to discover new medicines. It leverages DeepMind's AlphaFold technology to predict protein interactions with other molecules, applying this to a broader range of biological molecules. Isomorphic Labs has partnered with pharmaceutical giants like Eli Lilly and Novartis and is primarily focused on oncology and immunology.
Demis Hassabis, founder and CEO of Isomorphic Labs, stated that the funding will enhance their AI research and development efforts and expand their team. The company has been on a rapid growth trajectory since its inception in 2021, having quadrupled its R&D spending in 2023.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 31 Anthropic IPO Filing Details Nearly $900 Billion in Future Obligations Oct 31 Baseten Set to Raise Funding at Up to $30 Billion Valuation, Bloomberg Reports Oct 31 Talky Labs Raises €1.5 Million for AI Accounting Platform Oct 31 Ares Intelligence Raises €2.9 Million for AI Adoption Planning Oct 31 Pixel Systems Raises €2.7 Million for AI Content DetectionMore from Life Sciences
Oct 31 AI Agent Controls Brain Injection in Live Mouse After Claude Opus Refuses Oct 31 Patient Sues Allegheny Health Network and Highmark Over Abridge AI Recordings Oct 31 OpenAI Releases GPT-Rosalind-6 for Approved Biology Researchers Oct 30 Surveys Find Widespread AI Chatbot Use Among Teens and Tweens Oct 30 Widow Sues OpenAI and Luka Over Husband's SuicideAI Funding Brief
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
ALLOX Raises $10.5 Million for AI Drug Discovery Platform
Adsilico Raises £10 Million for Virtual Medical Device Testing
Formation Bio Forms $600 Million Drug Development Fund
Symbe Raises $5.7 Million for AI Sales Platform
XRlabs Raises €7.48 Million for Surgical AI
Daily AI Brief: the AI news that matters, in your inbox.